Provided by Tiger Trade Technology Pte. Ltd.

Cartesian Therapeutics

7.36
+0.14001.94%
Post-market: 7.360.00000.00%19:30 EDT
Volume:200.38K
Turnover:1.49M
Market Cap:222.68M
PE:-1.27
High:8.05
Open:7.32
Low:7.29
Close:7.22
52wk High:11.00
52wk Low:5.60
Shares:30.26M
Float Shares:12.40M
Volume Ratio:1.30
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.7983
EPS(LYR):-5.0200
ROE:-7029.26%
ROA:-17.43%
PB:-1.78
PE(LYR):-1.47

Loading ...

Cartesian Therapeutics Q2 2026 earnings: R&D spending rises as Phase 3 advances

TradingKey
·
Aug 06

Cartesian Therapeutics Q2 EPS $0.46 Beats $(0.86) Estimate

Benzinga Earnings
·
Aug 06

Cartesian Therapeutics Q2 FY26 Net Income Slips 0.74% to $15.8 Million

Reuters
·
Aug 06

Cartesian Therapeutics Inc Q2 Operating Income USD -29.155 Million

THOMSON REUTERS
·
Aug 06

Cartesian Therapeutics: Phase 3 Aurora Trial of Descartes-08 in Myasthenia Gravis Data Expected in 1Q27, Bla Planned for Mid-2027

THOMSON REUTERS
·
Aug 06

Press Release: Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 06

Cartesian Therapeutics Inc Expected to Post a Loss of 87 Cents a Share - Earnings Preview

Reuters
·
Aug 03

Cartesian Therapeutics Grants Inducement Stock Options for 238,700 Shares at $10.18 to New Hires

Reuters
·
Jul 02

Cartesian Therapeutics Announces New Employment Inducement Grants

GlobeNewswire
·
Jul 02

Cartesian Therapeutics (RNAC) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Jul 01

Cartesian Therapeutics Shareholders Back Directors and Governance Measures

TIPRANKS
·
Jun 18

Cartesian Therapeutics shareholders elect Class I director slate at annual meeting

Reuters
·
Jun 18

Cartesian Therapeutics grants new hire stock option for 6,100 shares at $5.86

Reuters
·
Jun 13

Cartesian Therapeutics Announces New Employment Inducement Grant

GlobeNewswire
·
Jun 13

Wedbush Sticks to Their Buy Rating for Cartesian Therapeutics (RNAC)

TIPRANKS
·
Jun 11

Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Cartesian Therapeutics (RNAC) and Abbott Laboratories (ABT)

TIPRANKS
·
Jun 10

Cartesian Therapeutics Price Target Maintained With a $44.00/Share by BTIG

Dow Jones
·
Jun 10

BUZZ-U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj

Reuters
·
Jun 09

BUZZ-U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental

Reuters
·
Jun 09

Cartesian Therapeutics Shares Rise on Licensing Deal for WestGene Delivery Platform

Dow Jones
·
Jun 09